NASDAQ:TNYA | Cash Flow Statement | Tenaya Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$43.39M
2026-03-31-$19.27M$1.76M-$19.23M$11,000.00-$11,000.00-$415,000.00
2025-12-31-$20.18M$1.83M-$13.94M$67,000.00-$67,000.00$58.24M
2025-09-30-$20.28M
2025-06-30-$23.28M
2025-03-31-$26.86M$2.66M-$23.11M$383,000.00$22.3M$50.26M
2024-12-31-$23.84M$2.09M-$18.39M$204,000.00$14.1M$377,000.00
2024-09-30-$25.63M
2024-06-30-$29.43M
2024-03-31-$32.23M$2.16M-$28.66M$564,000.00-$4.49M$46.77M
2023-12-31-$29.94M$2.18M-$21.92M$394,000.00-$14.92M$371,000.00
2023-09-30-$29.14M
2023-06-30-$33.27M
2023-03-31-$31.74M$2.13M-$30.29M$629,000.00$8.06M-$501,000.00
2022-12-31-$33.52M$2.12M-$22.68M$795,000.00$5.97M$77.49M
2022-09-30-$30.7M
2022-06-30-$28.4M
2022-03-31-$31.06M$966,000.00-$28.76M$8.6M$16.43M$15,000.00
2021-12-31-$26.15M$791,000.00-$16.35M$12.55M-$62.58M$0.00-$21,000.00
2021-09-30-$18.26M
2021-06-30-$15.21M
2021-03-31-$13.1M$689,000.00-$15.79M$4.32M-$4.32M$20.02M
2020-12-31-$10.32M$658,000.00-$10.4M$8.18M-$8.18M$0.00$85.92M
2020-09-30-$10.3M
2020-06-30-$8.73M
2020-03-31-$9.05M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$90.6M$8.44M-$68.26M$618,000.00$56.08M$108.41M
2024-12-31-$111.13M$8.47M-$90.5M$1.03M$1.13M$47.75M
2023-12-31-$124.08M$8.69M-$102.07M$1.24M$48.72M$4.05M
2022-12-31-$123.67M$6.47M-$104.42M$20.63M$83.65M$77.77M
2021-12-31-$72.72M$2.96M-$60.81M$25.12M-$238.56M$13,000.00$208.97M
2020-12-31-$38.4M$2.48M-$35.45M$9.76M-$7.01M$1,000.00$147.27M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.